글로벌 옴 치료 시장 - 업계 동향 및 2028년까지의 예측

옴 치료 시장의 시장 분석 및 통찰력

Data Bridge Market Research는 옴 치료가 2021-2028년 예측 기간 동안 약 5.40%의 CAGR을 보일 것이라고 분석했습니다. 표적 치료 모드에 대한 수요 증가, 신약 및 치료법 개발을 위한 연구 개발 활동 급증, 피부 질환의 높은 유병률, 이 질병의 고도로 전염성 있는 특성, 의료 인프라 개발에 대한 지출 증가가 옴 치료 시장 성장에 기여하는 주요 요인입니다.

옴은 Sarcoptes scabiei라고 알려진 미세한 진드기에 의해 발생하는 전염성 피부 감염입니다. 이 진드기는 피부에서 번식 주기를 보이며 한 진드기에서 다른 진드기로 퍼질 수 있습니다. 옴은 여드름과 같으며 피부에 발진과 가려움을 유발합니다. 옴은 가려움증이 있는 성질을 가지고 있으며 일반적으로 겨드랑이, 손목, 손가락 사이, 팔꿈치와 같은 부위에서 발견됩니다.

전 세계적으로 옴의 유병률이 증가하고 치료 옵션에 대한 인식이 높아지는 것은 시장 성장을 촉진하는 주요 요인입니다. 의료 인프라 개발에 대한 지출 증가, 인구의 위생 불량, 시장 참여자 간의 전략적 협력 비율의 급증도 시장 성장을 촉진하는 다른 요인입니다. 개인의 가처분 소득 증가는 수익성 있는 시장 성장 기회를 창출할 또 다른 간접적인 결정 요인입니다.

그러나 개발도상국과 저개발 경제권에서 많은 수의 홈케어 치료제와 불리한 환불 시나리오는 시장 성장에 큰 도전이 될 것입니다. 또한, 약물의 연구 개발 능력과 부작용과 관련된 높은 비용은 시장 성장률을 더욱 떨어뜨릴 것입니다. 시장에서 약물 승인에 부과된 엄격한 규제도 시장 성장률을 방해할 것입니다.

This scabies treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on scabies treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Scabies Treatment Market Scope and Market Size

The scabies treatment market is segmented on the basis of type, prescription medication, over the counter medication, route of administration, end users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the scabies treatment market is segmented into typical scabies, nodular scabies and Norwegian scabies.
• On the basis of prescription medication, the scabies treatment market is segmented into elimite, lindane, eurax and others.
• On the basis of over the counter medication, the scabies treatment market is segmented into sulphur soaps and creams, calamine lotion and others.  
• On the basis of route of administration, the scabies treatment market is segmented into oral, injectable and others.
• On the basis of end users, the scabies treatment market is segmented into hospitals, home care, speciality clinics, ambulatory services and others.
• On the basis of distribution channel, the scabies treatment market is segmented into hospital pharmacy, online pharmacy, retail pharmacy and others.

Scabies Treatment Market Country Level Analysis

The scabies treatment market is segmented on the basis of type, prescription medication, over the counter medication, route of administration, end users and distribution channel.

The countries covered in the scabies treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

Asia-Pacific dominates the scabies treatment market owing to the high prevalence of infectious diseases and large population base in this region. Asia-Pacific is projected to undergo substantial gains during the forecast period. This is because of the rising expenditure to develop healthcare infrastructure and increasing personal disposable income.

The country section of the scabies treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The scabies treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Scabies Treatment Market Share Analysis

The scabies treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to scabies treatment market.

The major players covered in the scabies treatment market report are BJAIN, Encube Ethicals, Perrigo Company plc, Trio Lifescience Private Limited., Incepta Pharmaceuticals Ltd., Aktis Pharma India Pvt Ltd., Mankind Pharma, PalsonsDerma, Abbott, NuLife Pharmaceuticals, HH Pharma, Renovision Exports Pvt. Ltd., Salvepharma, Aristo Pharma, Curatio, Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, ANI Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC, CHEIRON PHARMA GmbH and Aurobindo Pharma among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-50251